Trial Profile
Bioavailability study of 7-day rasagiline patch (TPU-002RA)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Dec 2014
Price :
$35
*
At a glance
- Drugs Rasagiline (Primary) ; Rasagiline
- Indications Parkinson's disease
- Focus Pharmacokinetics; Registrational
- Sponsors Teikoku Pharma USA
- 10 Dec 2014 New trial record
- 02 Dec 2014 Results published in Teikoku Pharma USA media release.